Management of fertility in women with familial hypercholesterolaemia: summary of NICE guidance
- 18 February 2009
- journal article
- Published by Wiley in BJOG: An International Journal of Obstetrics and Gynaecology
- Vol. 116 (4), 478-479
- https://doi.org/10.1111/j.1471-0528.2008.02084.x
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry studyEuropean Heart Journal, 2008
- Risk of congenital anomalies in pregnant users of statin drugsBritish Journal of Clinical Pharmacology, 2007
- Marked changes in plasma lipids and lipoproteins during pregnancy in women with familial hypercholesterolemiaAtherosclerosis, 2006
- Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmesJournal of Medical Screening, 2006
- Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease riskJournal of Medical Genetics, 2006
- Mechanistic and epidemiologic considerations in the evaluation of adverse birth outcomes following gestational exposure to statinsAmerican Journal of Medical Genetics Part A, 2004
- Genetic Causes of Monogenic Heterozygous Familial Hypercholesterolemia: A HuGE Prevalence ReviewAmerican Journal of Epidemiology, 2004
- Myocardial infarction and third generation oral contraceptives: aggregation of recent studies.Human Reproduction, 2002
- Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical managementAtherosclerosis, 1999
- Postmarketing surveillance of lovastatin and simvastatin exposure during pregnancyReproductive Toxicology, 1996